A stem cell trial which could bring hope to many people with spinal cord injury has received substantial funding of $25 million (£15.3 million).
The California Institute for Regenerative Medicine (CIRM) has awarded the funding to Geron Corp, which is carrying out the first Food and Drug Administration-approved human embryonic stem cell trial.
Robert Klein, CIRM chairman, said: "We need to be prepared to stand by the heroic patients and the companies as they face these challenges and solve the problems that stand in the way of the recovery of patients from paralysis."
This follows the launch of the first neural stem cell trial for spinal cord injury by StemCells Inc.
Scientists are to use human neural stem cells which have the ability to transform into any of the central nervous system cell types.
The trial is designed to assess the safety of the procedure as well as observe the potential benefits to the patient, such as improved sensation, motor function and bowel or bladder function.
News by Serious Law. Expert legal assistance for those affected by spinal injury
Posted by Paul Breen
